(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Chronic Knee Pain
Tanta UniversitySmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
7 Active assets in the Chronic Knee Pain cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
DEXAMETHASONE Slagelse Hospital | Phase 4 | BB |
Phenol University of Manitoba | Phase 4 | BB |
Doxycycline Campbell Clinic | Phase 2 | CCC |
LIDOCAINE Tanta University | N/A | D |
Triamcinalone Tanta University | N/A | D |
92.3% TO NMT 93.8% ETHANOL BY WEIGHT IN WATER Tanta University | N/A | D |
Bxcl501 Tanta University | N/A | D |
Same molecule, other indications
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →